DelveInsight's "VUITY Market Size, Forecast, and Market Insight Report" highlights the details around VUITY, which is a ...

LENZ Therapeutics, Inc.'s LNZ100 eye drops show strong phase 3 results for presbyopia, outperforming competitors. Click here ...

VUITY, an FDA-approved eye drop for presbyopia, has significant market potential given the growing aging population. With an estimated 128 million Americans affected by presbyopia, VUITY offers ...

In today’s digitally driven world, the average person spends a significant portion of their day looking at screens—phones, ...

Ocuphire meanwhile also reported results from a phase 2 trial with its presbyopia therapy Nyxol (phentolamine) plus low-dose pilocarpine that inhibits the contraction of smooth muscle of the iris ...

Presbyopia impacts an estimated 128 million ... size to restore in your vision while not overstimulating the ciliary muscle. Awareness continues for this campaign and has over 50 KOLs and over ...

“Common conditions in older people include presbyopia (difficulty focusing ... looking at a screen and it puts an extra burden on the muscles that help the eyes to focus,” notes Mark Shelton ...

Presbyopia (from a Greek term meaning “old eye”) is a ... that enable us to see in low light; at the same time, the muscles that control our pupils weaken, causing the pupils to get smaller. By age 50 ...

Lumenis announced the launch of OptiLift, a dynamic muscle stimulation technology intended to improve lower eyelid laxity, ...